Research Papers

25 of 610 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
New advances in genomics and epigenetics in antiphospholipid syndrome.
López-Pedrera C; Cerdó T; Jury EC; Muñoz-Barrera L; Escudero-Contreras A; Aguirre MA; Pérez-Sánchez C.
Rheumatology (Oxford) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations.
Gaspar P; Sciascia S; Tektonidou MG.
Rheumatology (Oxford) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Inhibition of TLR4 signalling to dampen joint inflammation in osteoarthritis.
Bartels YL; van Lent PLEM; van der Kraan PM; Blom AB; Bonger KM; van den Bosch MHJ.
Rheumatology (Oxford) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Addressing the unmet needs of transitional care in juvenile idiopathic arthritis.
Şahin N; Sönmez HE; Aktay Ayaz N; Sözeri B.
Rheumatology (Oxford) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Characteristics and course of patients with AA amyloidosis: single centre experience with 174 patients from Turkey.
Bektas M; Koca N; Oguz E; Sari S; Dagci G; Ince B; Ozer PK; Agargun BF; Yalcinkaya Y; Artim-Esen B; Ocal L; Inanc M; Gul A.
Rheumatology (Oxford) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Patterns and determinants of response to novel therapies in juvenile and adult-onset polyarthritis.
Triaille C; Quartier P; De Somer L; Durez P; Lauwerys BR; Verschueren P; Taylor PC; Wouters C.
Rheumatology (Oxford) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Clonal haematopoiesis and UBA1 mutations in individuals with biopsy-proven giant cell arteritis and population-based co…
Salzbrunn JB; van Zeventer IA; de Graaf AO; Kamphuis P; van Bergen MGJM; van Sleen Y; van der Reijden BA; Schuringa JJ; Brouwer E; Diepstra A; Jansen JH; Huls G.
Rheumatology (Oxford) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseases.
Taylor PC; Choy E; Baraliakos X; Szekanecz Z; Xavier RM; Isaacs JD; Strengholt S; Parmentier JM; Lippe R; Tanaka Y.
Rheumatology (Oxford) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The impact of 2023 EMA recommendations on patients treated with JAK inhibitors: real-life experience from a prospective…
Tomelleri A; Benanti G; Cariddi A; Calvisi SL; Baldissera E; Boffini N; Matucci-Cerinic M; Dagna L.
Rheumatology (Oxford) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Pyrin variant E148Q potentiates inflammasome activation and the effect of pathogenic mutations in cis.
Reygaerts T; Laohamonthonkul P; Hrovat-Schaale K; Moghaddas F; Baker PJ; Gray PE; Masters SL.
Rheumatology (Oxford) (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Autoimmune diseases exhibit shared alterations in the gut microbiota.
Wang T; Sternes PR; Guo XK; Zhao H; Xu C; Xu H.
Rheumatology (Oxford) (Unknown)
Published: 2024
5/6 Transparent
Data Code Funding Declared
Inaugural dropped head syndrome and camptocormia in inflammatory myopathies: a retrospective study.
Robert M; Lessard LER; Bouhour F; Petiot P; Fenouil T; Svahn J; Fiscus J; Fabien N; Perard L; Robinson P; Durieu I; Coury F; Streichenberger N; Hot A; Gallay L.
Rheumatology (Oxford) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Tongue necrosis in anti-neutrophil myeloperoxidase antibody-associated vasculitis.
Korsten P; Hakroush S; Rödel R; Tampe B.
Rheumatology (Oxford) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Vitamin D is associated with reduced risk of Sjögren's syndrome: a Mendelian randomization study.
Zhao SS; Burgess S.
Rheumatology (Oxford) (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Rescue therapy of antisynthetase syndrome with CD19-targeted CAR-T cells after failure of several B-cell depleting anti…
Taubmann J; Knitza J; Müller F; Völkl S; Aigner M; Kleyer A; Gary R; Kretschmann S; Boeltz S; Atzinger A; Kuwert T; Roemer F; Uder M; Mackensen A; Schett G.
Rheumatology (Oxford) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Accelerated atherosclerosis in systemic lupus erythematosus: don't forget the devil we know!
van Leuven SI; Major AS.
Rheumatology (Oxford) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
S100A4-neutralizing monoclonal antibody 6B12 counteracts the established experimental skin fibrosis induced by bleomyci…
Švec X; Štorkánová H; Trinh-Minh T; Tran MC; Štorkánová L; Hulejová H; Oreská S; Heřmánková B; Bečvář R; Pavelka K; Vencovský J; Klingelhöfer J; Hussain RI; Hallén J; Šenolt L; Distler JHW; Tomčík M.
Rheumatology (Oxford) (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
A prospective survey on therapeutic inertia in psoriatic arthritis (OPTI'PsA).
Lioté F; Constantin A; Dahan É; Quiniou JB; Frazier A; Sibilia J.
Rheumatology (Oxford) (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Sustained cell-mediated but not humoral responses in rituximab-treated rheumatic patients after vaccination against SAR…
Thomas Κ; Grigoropoulos I; Alexopoulou P; Karofylakis E; Galani I; Papadopoulou KK; Tsiavou A; Ntourou A; Mavrou E; Qevani I; Katsimbri P; Koutsianas C; Mavrea E; Vassilopoulos D; Pournaras S; Tsiodras S; Boumpas D; Antoniadou A.
Rheumatology (Oxford) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Belimumab and antimalarials combined against renal flares in patients treated for extra-renal systemic lupus erythemato…
Gomez A; Jägerback S; Sjöwall C; Parodis I.
Rheumatology (Oxford) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
EPCR deficiency ameliorates inflammatory arthritis in mice by suppressing the activation and migration of T cells and d…
Xue M; Lin H; Liang HPH; Bereza-Malcolm L; Lynch T; Sinnathurai P; Weiler H; Jackson C; March L.
Rheumatology (Oxford) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Prognostic and predictive markers of systemic sclerosis-associated interstitial lung disease in a clinical trial and lo…
Ghuman A; Khanna D; Lin CJF; Furst DE; Raghu G; Martinez FJ; Zucchetto M; Huang S; Jennings A; Nihtyanova SI; Denton CP.
Rheumatology (Oxford) (Unknown)
Published: 2024
5/6 Transparent
Data Registered Funding Declared
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospectiv…
Muratore F; Marvisi C; Cassone G; Boiardi L; Mancuso P; Besutti G; Spaggiari L; Casali M; Croci S; Versari A; Giorgi Rossi P; Catanoso M; Costantini M; Galli E; Salvarani C.
Rheumatology (Oxford) (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
Adherence to dietary guidelines, and the risk of developing rheumatoid arthritis: results from a nested case-control st…
Bäcklund RT; Drake I; Bergström U; Compagno M; Sonestedt E; Turesson C.
Rheumatology (Oxford) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Treatment with mycophenolate mofetil is associated with improved nailfold vasculature in systemic sclerosis.
Wildt M; Andréasson K; Hamberg V; Hesselstrand R; Wuttge DM.
Rheumatology (Oxford) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared